AR011105A1 - PARENTERAL LIPOSOMA FORMULATION THAT REDUCES PAIN - Google Patents

PARENTERAL LIPOSOMA FORMULATION THAT REDUCES PAIN

Info

Publication number
AR011105A1
AR011105A1 ARP980100470A AR011105A1 AR 011105 A1 AR011105 A1 AR 011105A1 AR P980100470 A ARP980100470 A AR P980100470A AR 011105 A1 AR011105 A1 AR 011105A1
Authority
AR
Argentina
Prior art keywords
demethyl
deoxy
parenteral
liposoma
formulation
Prior art date
Application number
Other languages
Spanish (es)
Original Assignee
Abbott Lab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Abbott Lab filed Critical Abbott Lab
Publication of AR011105A1 publication Critical patent/AR011105A1/en

Links

Abstract

Formulaciones parenterales que reducen el dolor, que comprenden a una droga de macrolida atrapada en una vesícula de liposoma. La droga de macrolida seselecciona del grupo formado por los derivados de las eritromicinas A, B, C y D; claritromicina,azitromicina, diritromicina, josamicina, midecamicina,kitasamicina, roxitromicina, rokitamicina, oleanadomicina, miocamicina, fluritromicina, rosaramicina, 8,9-anhidro-4-deoxi-3-N-desmetil-3-N-etileritromicina B 6,9-hemiacetal,8,9-anhidro-4- deoxi-3-N-desmetil-3-N- etileritromicina A 6,9-hemiacetal, y carbamato 11,12-cíclico 11-amino-11-deoxi-3-oxo-5-O-desosaminil-6-O-[1-3-quinolil-2-propenil]-eritronoluro A. Las formulaciones son efectivas para reducirsustancialmente el dolor e n el lugarde la inyeccion típicamente asociadas con la inyeccion de antibioticos de macrolida.Parenteral pain-reducing formulations, comprising a macrolide drug trapped in a liposome vesicle. The macrolide drug is selected from the group consisting of erythromycin derivatives A, B, C, and D; clarithromycin, azithromycin, dirithromycin, josamycin, midecamycin, kitasamycin, roxithromycin, rokitamycin, oleanadomycin, myocamycin, flurithromycin, rosyramycin, 8,9-anhydro-4-deoxy-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-demethyl-3-N-meme hemiacetal, 8,9-anhydro-4-deoxy-3-N-desmethyl-3-N-ethylerythromycin A 6,9-hemiacetal, and 11,12-cyclic carbamate 11-amino-11-deoxy-3-oxo-5 -O-desosaminyl-6-O- [1-3-quinolyl-2-propenyl] -eritronolide A. The formulations are effective in substantially reducing pain at the injection site typically associated with injection of macrolide antibiotics.

ARP980100470 1997-02-04 1998-02-03 PARENTERAL LIPOSOMA FORMULATION THAT REDUCES PAIN AR011105A1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US76406497A 1997-02-04 1997-02-04

Publications (1)

Publication Number Publication Date
AR011105A1 true AR011105A1 (en) 2000-08-02

Family

ID=45724859

Family Applications (1)

Application Number Title Priority Date Filing Date
ARP980100470 AR011105A1 (en) 1997-02-04 1998-02-03 PARENTERAL LIPOSOMA FORMULATION THAT REDUCES PAIN

Country Status (1)

Country Link
AR (1) AR011105A1 (en)

Similar Documents

Publication Publication Date Title
CA2269054A1 (en) Method of treatment of heart disease caused by chlamydia pneumoniae
ATE214603T1 (en) STABLE MACROLIDES AND MACROLIDE VACCINE COMPOSITIONS
CA2316919A1 (en) Novel macrolides
FI955913A0 (en) New erythromycin derivatives, methods for their preparation and their use as drugs
FI964395A (en) New erythromycin derivatives, method for their preparation and their use as drugs
BR9604880A (en) Compound composition dosage unit form methods for administering a biologically active agent for preparing a composition for administering an active agent and for preparing a compound and pharmacological composition
ATE252108T1 (en) 3'-N-OXIDE,3'-N-DIMETHYLAMINE,9-OXIMES ERYTHROMYCIN A DERIVATIVES
NO20001439D0 (en) 3'-N-modified 6-O-substituted erythromycin ketolide derivatives with antibacterial activity
MX9304301A (en) DERIVATIVES OF ANTIBIOTIC MACROLIDES WITH A RING OF 16 MEMBERS.
PT1032581E (en) 6-O-ALKYLERITROMYCIN A CHEMICAL SYNTHETIC
ATE241638T1 (en) 15-MEMBER KETOLIDE LACTAMES WITH ANTIBACTERIAL EFFECT
DK1004592T3 (en) New erythromycin derivatives, their preparation and their use as drugs
ES526529A0 (en) A PROCEDURE FOR THE PREPARATION OF A MACROLIDE
AR011105A1 (en) PARENTERAL LIPOSOMA FORMULATION THAT REDUCES PAIN
ATE261425T1 (en) ERYTHROMYCIN DERIVATIVES WITH ANTIBIOTIC ACTION
ATE289609T1 (en) MACROLIDE LHRH ANTAGONISTS
NZ506622A (en) 3',3'-N-bis-substituted macrolide LHRH antagonists
CO4920212A1 (en) PARENTERAL FORMULATION IN LIPOSOMES FOR THE REDUCTION OF PAIN
ES2144154T3 (en) DERIVATIVES OF ERYTHROMYCIN A 9-0-OXIME GIVEN WITH ANTIBIOTIC ACTIVITY.
FR2751656B1 (en) NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
DE69915327D1 (en) DERIVATIVES OF ERYTHROMYCIN, CLARITHROMYCIN, ROXITHROMYCIN OR AZITHROMYCIN WITH ANTIBIOTIC AND MUCOLYTIC EFFECT
MX9606111A (en) Antibiotic macrolides.
OA09447A (en) New macrolide derivatives, their preparation process and the pharmaceutical compositions which contain them.
FR2757518B1 (en) NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS
FR2792637B1 (en) NOVEL ERYTHROMYCIN DERIVATIVES, THEIR PREPARATION PROCESS AND THEIR APPLICATION AS MEDICAMENTS

Legal Events

Date Code Title Description
FB Suspension of granting procedure